1. Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?
- Author
-
Sharp FR, Tomitaka M, Bernaudin M, and Tomitaka S
- Subjects
- Animals, GABA Agonists pharmacology, Humans, Psychoses, Substance-Induced pathology, Receptors, GABA drug effects, Receptors, GABA physiology, Schizophrenia pathology, Excitatory Amino Acid Antagonists pharmacology, Limbic System drug effects, Models, Neurological, Psychoses, Substance-Induced etiology, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors, Thalamus drug effects
- Abstract
Non-competitive NMDA receptor antagonists, such as phencyclidine, ketamine and MK801, produce psychosis in humans. These drugs also produce injury to cingulate-retrosplenial cortex in adult rodents that can be prevented by GABA-receptor agonists and antipsychotics such as haloperidol and clozapine. MK801 injections into anterior thalamus reproduce limbic cortex injury, and GABA-receptor agonist injections into anterior thalamus prevent injury produced by systemic MK801. Inhibition of NMDA receptors on GABAergic thalamic reticular nucleus neurons might activate thalamocortical 'injury' circuits in animals. Pathological activation of thalamocortical circuits might also mediate the psychosis produced by NMDA-receptor antagonists in humans, and might contribute to psychosis in schizophrenia.
- Published
- 2001
- Full Text
- View/download PDF